Angiogenesis by gene therapy: A new horizon for myocardial revascularization?

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 490-497

  Lewis, Basil S ^a   Flugelman, Moshe Y ^a   Weisz, Anat ^a   Keren Tal, Iris ^a   Schaper, Wolfgang ^b  

^a Laboratory of Molecular Dermatology   (Israel)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Angiogenesis; Animal; Atherosclerosis; Gene transfer; Growth factor; Human; Myocardial ischemia; Vasculogenesis

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; CONTROLLED STUDY; EDEMA; GENE TRANSFER; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMANGIOMATOSIS; HUMAN; HUMAN CELL; INTRACORONARY INFUSION; LIMB ISCHEMIA; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LYMPHOKINES; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030831412     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00170-3     Document Type: Review

References (61)

1. Schaper W, Schaper J. Collateral circulation - heart, brain, kidney, limbs. Boston, Dordrecht, London: Kluwer Academic Publishers, 1993.
2. Hariawala M., Horowitz J.R., Esakof D.et al. Vascular endothelial growth factor accelerates collateral development in porcine hearts. J Surg Res. 63:1996;77-82.
3. Sunderkotter C., Goebeler M., Schulze-Osthoff K., Bhardwaj R., Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther. 51:1991;195-216.
4. Shen H., Clauss M., Ryan J.et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood. 81:1993;2767-2773.
5. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:1996;3336-3343.
6. Cuevas P., Gonzalez A.M., Carceller F., Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ Res. 69:1991;360-369.
7. Edelman E.R., Nugent M.A., Smith L.T., Karnovsky M.J. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 89:1992;465-473.
8. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral- and peripheral conductance after femoral artery occlusion. 1997;in press.
9. Shyy Y.J., Hsieh H.J., Usami S., Chien S. Fluid shear stress induces a biphasic response of human monocytic chemotactic protein-1 gene expression in vascular endothelium. Proc Natl Acad Sci USA. 91:1994;4672-4682.
10. Wang D.L., Wung B.S., Shyy Y.J.et al. Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells: effects of mechanical strain on monocyte adhesion to endothelial cells. Circ Res. 77:1995;294-302.
11. Wung B.S., Cheng J.J., Chao Y.F., Lin J., Shyy Y.J., Wang D.L. Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells. Am J Physiol. 270:1996;H1462-H1468.
12. Shing Y., Folkman J., Sullivan J., Butterfield R., Murray J., Klagsbrun M. Heparin-affinity purification of a tumor-derived capillary endothelial cell growth factor. Science. 223:1984;1296-1299.
13. Ware J.A., Simons M. Angiogenesis in ischemic heart disease. Nature Med. 3:1997;158-164.
14. Baffour R., Berman J., Garb J.L., Rhee S.W., Kaufman J., Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg. 16:1992;181-191.
15. Pu L.Q., Sniderman A.D., Brassard R.et al. Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation. 88:1993;208-215.
16. Yanagisawa-Miwa A., Uchida Y., Nakamura F.et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1992;1401-1403.
17. Unger E.F., Banai S., Shou M.et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 266:1994;1588-1595.
18. Giordano F.J., Ping P., McKirnan D.et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2:1996;534-539.
19. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 161:1989;851-855.
20. Keck P.J., Hauser S.D., Krivi G.et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
21. Connolly D.T., Olander J.V., Heuvelman D.et al. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem. 264:1989;20017-20024.
22. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
23. Conn G., Soderman D.D., Schaeffer M.T., Wile M., Hatcher V.B., Thomas K.A. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci. 87:1990;1323-1327.
24. Gospodarowicz D., Massoglia S., Cheng J., Fujii D.K. Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries. J Cell Physiol. 127:1986;121-136.
25. Klagsbrun M., Amore P.A. Regulators of angiogenesis. Annu Rev Physiol. 53:1991;217-239.
26. Banai S., Shweiki D., Pinson A., Chandra M., Lazarovici G., Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 28:1994;1176-1179.
27. Hashimoto E., Ogita T., Nakaoka T., Matsuoka R., Takao A., Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol. 267:1994;1948-1954.
28. Banai S., Jaklitsch M.T., Shou M.et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
29. Bauters C., Asahara T., Zheng L.P.et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 21:1995;314-325.
30. Takeshita S., Zheng L.P., Brogi E.et al. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 93:1994;662-670.
31. Bauters C., Asahara T., Zheng L.P.et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 91:1995;2802-2809.
32. Takeshita S., Pu L.Q., Stein L.A.et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation. 90(2):1994;228-234.
33. Joukov V., Pajusola K., Kaipainen A.et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
34. Ferrara N., Carver-Moore K., Chen H.et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
35. Levy A.P., Levy N.S., Loscalzo J.et al. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 76:1995;758-766.
36. Westernacher D., Schaper W. A novel heart derived inhibitor of vascular cell proliferation. J Mol Cell Cardiol. 27:1995;1535-1543.
37. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial factor. Biol Chem. 269:1994;26988-26995.
38. Waltenberger J., Mayr U., Pentz S., Hombach V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation. 94:1996;1647-1654.
39. Clauss M., Weich H., Breier G.et al. The vascular endothelial growth factor FLT-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 271:1996;17629-17634.
40. Waltenberger J., Mayr U., Frank H., Hombach V. Suramin is a potent inhibitor of vascular growth factor. Interaction with KDR as a potential molecular basis for its antiangiogenic action. J Mol Cell Cardiol. 28:1996;1523-1529.
41. Brogi E., Schatteman G., Wu T.et al. Hypoxia-induced paracrine regulation of VEGF receptor expression. J Clin Invest. 97:1996;469-476.
42. Harats D., Kurihara H., Belloni P.et al. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promotor. J Clin Invest. 95:1995;1335-1344.
43. Kasahara N., Dozy A.M., Kan Y.W. Tissue-specific targeting of retroviral vectors through ligand receptor interactions. Science. 266:1994;1326.
44. Majesky M. A little VEGF goes a long way. Circulation. 94:1996;3062-3064.
45. Isner J.M., Walsh K., Symes J.et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 91:1995;1687-1692.
46. Dichek D.A., Neville R.F., Zwiebel J.A., Freeman S.M., Leon M.B., Anderson W.F. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 80:1989;1347-1353.
47. Flugelman M.Y., Virmani R., Leon M.B., Bowman R.L., Dichek D.A. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to pulsatile flow. Circ Res. 70:1992;348-354.
48. Flugelman M.Y., Rome J.J., Virmani R., Newman K.D., Dichek D.A. Detection of genetically engineered endothelial cells seeded on endovascular prosthesis ten days after in vivo deployment. J Mol Cell Cardiol. 25(Suppl. 1):1993;S38.
49. Tsurumi Y., Takeshita S., Chen D.et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 94:1996;3281-3290.
50. Laitinen M., Pakkanen T., Luoma J.et al. Local adventitial VEGF gene transfer reduces neointima formation in rabbit carotid arteries. Circulation. 94(Suppl. 1):1996;I-637.
51. Landau C., Jacobs A.K., Haudenschild C.C. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J. 129:1995;924-931.
52. Van der Gissen W.J., Serruys P.W., Visser W.J., Verdouw P.D., van Schalkwijk W.P., Jongkind J.F. Endothelialization of endovascular stents. J Intervent Cardiol. 1:1988;109-120.
53. Rome J.J., Shayani V., Flugelman M.Y.et al. Anatomic barriers determine the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Atheroscler Thromb. 14:1994;148-161.
54. Pasic Miralem X., Muller-Glauser W., Odermatt B., Lachat M., Seifert B., Turina M. Seeding with omental cells prevents late neointimal hyperplasia in small-diameter dacron grafts. Circulation. 92:1995;2605-2616.
55. Zilla P., Deutsch M., Meinhart J.et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg. 19:1994;540-548.
56. Riessen R., Rahimizadeh H., Blessing E., Takeshita S., Barry J.J., Isner J.M. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther. 4:1993;749-758.
57. Muhlhauser J., Pili R., Merrill M.J.et al. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or non-secreted forms of acidic fibroblast growth factor. Hum Gene Ther. 6:1995;1457-1465.
58. Nabel E.G., Yang Z.Y., Plautz G.et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 362:1993;844-846.
59. Aiello L.P., Avery R.L., Arrigg P.G.et al. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. New Engl J Med. 331:1994;1480-1487.
60. Melder R.J., Koenig G.C., Witwer B.P., Safabakhsh N., Munn L.L., Jain R.K. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2:1996;992-997.
61. Isner J.M., Pieczek A., Schainfeld R.et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischaemic limb. Lancet. 348:1996;370-374.